Rationale and Design of a Prospective, Multicenter, Phase II Clinical Trial of Safety and Efficacy Evaluation of Long Course Neoadjuvant Chemoradiotherapy Plus Tislelizumab Followed by Total Mesorectal Excision for Locally Advanced Rectal Cancer (NCRT-PD1-LARC Trial)
Annals of oncology（2022）
关键词
Neoadjuvant Therapy,Total Mesorectal Excision,Metastatic Colorectal Cancer,Adjuvant Chemotherapy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要